Msn Life Sciences Private Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is PIMAVANSERIN TARTRATE, with a corresponding US DMF Number 33292.
Remarkably, this DMF maintains an Active status since its submission on October 31, 2018, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of August 01, 2019, and payment made on July 08, 2019, indicating their dedication to facilitating drug approvals, Categorized as Type II